MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • Retinal Degeneration
    • Skincare
  • News & Media
  • Contact Us
MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • Retinal Degeneration
    • Skincare
  • News & Media
  • Contact Us
  •  
  • June 2016

AiVita Biomedical Receives FDA Approval for Phase II Ovarian Cancer Treatment

AIVITA Biomedical is an Irvine, CA based company focused on the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. We leverage our unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development.

Recent News

  • AIVITA Biomedical Announces Publication Comparing Clinical Outcomes in Patients Treated with AIVITA’s Immunotherapy and Other Immunotherapies
  • ROOT OF SKIN™ Skincare Products Sell Out in Tenth Consecutive Appearance on QVC Japan
  • AIVITA Biomedical Announces Publication Concerning a Predictive Biomarker for Melanoma Patients Treated with the Company’s Platform Immunotherapy
  • AIVITA CEO Dr. Hans Keirstead Honored as One of Canada’s ‘Seven Wonderers’ at Beakerhead Festival
  • AIVITA Biomedical to Present at Meeting on the Mesa and Other Investor, Oncology and Regenerative Medicine Conferences in October

Site Navigation

  • About Us
  • Programs
  • News & Media
  • Contact Us
Copyright © 2017 | AIVITA Biomedical